LRI Investments’s PTC Therapeutics PTCT Stock Holding History

LRI Investments’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$326	Buy	+4	New	+$289	﹤0.01%	1626

Other funds holding PTCT

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

LRI Investments's PTCT Position: Q2 2026 in Review

LRI Investments opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 4 shares worth $326. The stake represents ﹤0.01% of the portfolio and ranks #1626 among its holdings.

95 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

LRI Investments held 4 shares of PTC Therapeutics worth $326 as of Q2 2026.
PTC Therapeutics was a new LRI Investments position in Q2 2026.
PTC Therapeutics made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1626 holding.
95 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.